Building Bridges: QUAMED’s Collaborative Journey in Washington DC

The QUAMED executive director, Ed Vreeke, had the opportunity to meet with partners in Washington DC last week on Thursday and Friday. On Thursday, a meeting was held with PAHO representatives at their offices. We discussed the GSDP inspection course that we developed and facilitated last year for PAHO member states as well as other ...

QUAMED board: Edwin de Voogd has stepped down as treasurer

On behalf of the board and the entire QUAMED organization, we would like to express our appreciation to Edwin de Voogd for his excellent service on the board as treasurer and as a thought leader. We learned a lot from exchanges at the board level and from his contributions. Edwin always had great perspectives that ...

QUAMED: USAID Ready!

Early in 2023, OUAMED was notified that USAID would like to conduct a pre-award survey of our organisation.  A USAID pre-award survey is a required process to become a recognised and eligible USAID partner. The purpose of the survey is to assess financial management, internal controls, and the capacity necessary to effectively manage USAID funds ...

USAID MTaPS Webinars: Strengthening Regulatory Systems

Don’t miss out on the opportunity to join the upcoming USAID MTaPS webinars, your last chance to register! On Wednesday, April 17, from 8:00 to 9:30 am US EDT / 12:00 to 1:30 pm GMT, they will dive into the critical connection between sustainable local manufacturing, resilient health supply chains, and strong regulatory systems. Then, ...

Urgent Alert: Contaminated Propylene Glycol Detected in Medical Products

Attention healthcare professionals and regulatory authorities! Falsified (contaminated) USP/EP PROPYLENE GLYCOL has been detected in the WHO Eastern Mediterranean Region, specifically in Pakistan. The contaminated raw materials, not manufactured or supplied by DOW as confirmed, contain dangerously high levels of ethylene glycol, posing a severe health risk, particularly to children. Ethylene glycol ingestion can lead ...

SALAMA Centrale d’Achats de Médicaments Awarded GSDP QCP Certificate

We are very pleased to announce that our Independent Decision Committee (IDC) has issued a GSDP QCP certificate to SALAMA. SALAMA is the central medical store in Madagascar, created in 1996 by the Malagasy Government. Their mission consists of ensuring the procurement of essential generic medicines, medical consumables and medical equipment at affordable prices to public ...

African Medicines Agency Treaty: National Regulatory Perspectives

New research delves into the slow ratification process of the African Medicines Agency treaty, analyzing perspectives from national regulatory agencies across 45 African countries. Enabling factors like political will and desire for harmonization contrast with challenges such as slow progress and limited understanding. Addressing these can bolster continent-wide medicine regulation, ensuring quality and accessibility for ...

Summer Learning Adventure: Utrecht University’s Global Courses

Gear up for an exhilarating summer with Utrecht University, Netherlands! Join our international summer courses: Pharmacoepidemiology & Drug Safety from July 8-12, 2024, and Pharmaceutical Policy Analysis from July 15-19, 2024. Gain insights, connect globally, and elevate your academic journey! Register now at www.utrechtsummerschool.nl and delve into a summer of growth. For inquiries, contact Emma ...

Urgent Need for Supply Chain Transparency in Healthcare Manufacturing

Labour rights abuse in healthcare product manufacturing is a pressing concern. Data from high-income settings reveal concerning levels of risk, with up to 60% of products sourced from countries with high-risk ratings for labour abuses. Urgent global reforms are needed, emphasizing transparency in supply chains. Ethical procurement practices and supply chain transparency are crucial for ...

WHO’s Essential Tool: Tackling Antimicrobial Resistance with MIA

WHO has released the “WHO List of Medically Important Antimicrobials (MIA)” as a crucial tool to combat antimicrobial resistance (AMR) from non-human use. This guidance supports decision-making for authorities, veterinarians, and agricultural professionals to minimize AMR impact. The MIA categorizes antimicrobials by importance to human medicine, including those authorized exclusively for human use like plazomicin ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.